FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA Compliance for Peptide Therapy and BPC 157 Holt Law FDA to weigh easing limits on unproven peptides promoted by RFK Jr. New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, fda warning bpc 157 peptide products New Details 157 Emerging Use of BPC 157 in Orthopaedic Sports Medicine: A Systematic Review Nikhil Vasireddi, Henrik Hahamyan, Michael J. Salata, Michael Karns, Jacob G. Calcei, James E. Voos, John M. Apostolakos, 2025